- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 3 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
HEM.2: 17 residues within 4Å:- Chain A: P.260, I.261, I.264, A.313, H.316, V.317, S.320, Y.360, I.361, G.364, I.365, S.406, H.409, V.410, Y.413, F.432
- Chain B: C.322
14 PLIP interactions:14 interactions with chain A,- Hydrophobic interactions: A:P.260, A:I.264, A:A.313, A:V.317, A:V.317, A:Y.360, A:I.365, A:V.410, A:Y.413, A:Y.413, A:Y.413
- Salt bridges: A:K.257
- Metal complexes: A:H.316, A:H.409
HEM.8: 17 residues within 4Å:- Chain B: P.260, I.261, I.264, A.313, H.316, V.317, S.320, Y.360, I.361, G.364, I.365, S.406, H.409, V.410, Y.413, F.432
- Chain C: C.322
14 PLIP interactions:14 interactions with chain B,- Hydrophobic interactions: B:P.260, B:I.264, B:A.313, B:V.317, B:V.317, B:Y.360, B:I.365, B:V.410, B:Y.413, B:Y.413, B:Y.413
- Salt bridges: B:K.257
- Metal complexes: B:H.316, B:H.409
HEM.14: 17 residues within 4Å:- Chain A: C.322
- Chain C: P.260, I.261, I.264, A.313, H.316, V.317, S.320, Y.360, I.361, G.364, I.365, S.406, H.409, V.410, Y.413, F.432
14 PLIP interactions:14 interactions with chain C,- Hydrophobic interactions: C:P.260, C:I.264, C:A.313, C:V.317, C:V.317, C:Y.360, C:I.365, C:V.410, C:Y.413, C:Y.413, C:Y.413
- Salt bridges: C:K.257
- Metal complexes: C:H.316, C:H.409
- 3 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Covalent)
NAP.3: 20 residues within 4Å:- Chain A: G.37, S.38, G.39, D.40, F.41, S.60, R.61, N.62, A.92, I.93, H.94, H.97, S.100, V.116, S.117, N.118, N.147, V.149, S.150, A.151
20 PLIP interactions:20 interactions with chain A- Hydrophobic interactions: A:F.41, A:F.41
- Hydrogen bonds: A:S.38, A:S.38, A:D.40, A:F.41, A:S.60, A:R.61, A:R.61, A:I.93, A:H.94, A:S.100, A:N.118, A:N.118, A:S.150
- Salt bridges: A:R.61, A:H.94, A:H.94
- pi-Stacking: A:H.97
- pi-Cation interactions: A:R.61
NAP.9: 20 residues within 4Å:- Chain B: G.37, S.38, G.39, D.40, F.41, S.60, R.61, N.62, A.92, I.93, H.94, H.97, S.100, V.116, S.117, N.118, N.147, V.149, S.150, A.151
20 PLIP interactions:20 interactions with chain B- Hydrophobic interactions: B:F.41, B:F.41
- Hydrogen bonds: B:S.38, B:S.38, B:D.40, B:F.41, B:S.60, B:R.61, B:R.61, B:I.93, B:H.94, B:S.100, B:N.118, B:N.118, B:S.150
- Salt bridges: B:R.61, B:H.94, B:H.94
- pi-Stacking: B:H.97
- pi-Cation interactions: B:R.61
NAP.15: 20 residues within 4Å:- Chain C: G.37, S.38, G.39, D.40, F.41, S.60, R.61, N.62, A.92, I.93, H.94, H.97, S.100, V.116, S.117, N.118, N.147, V.149, S.150, A.151
20 PLIP interactions:20 interactions with chain C- Hydrophobic interactions: C:F.41, C:F.41
- Hydrogen bonds: C:S.38, C:S.38, C:D.40, C:F.41, C:S.60, C:R.61, C:R.61, C:I.93, C:H.94, C:S.100, C:N.118, C:N.118, C:S.150
- Salt bridges: C:R.61, C:H.94, C:H.94
- pi-Stacking: C:H.97
- pi-Cation interactions: C:R.61
- 3 x LBN: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine(Non-covalent)
LBN.4: 22 residues within 4Å:- Chain A: R.207, F.209, W.212, K.303, Q.304, L.307, F.310, F.311, M.314, A.318, S.372, A.375, V.376, S.378, I.379
- Chain B: M.314
- Chain C: L.368, G.369, S.372, V.376, T.377, V.382
16 PLIP interactions:5 interactions with chain C, 11 interactions with chain A- Hydrophobic interactions: C:L.368, C:V.376, C:T.377, C:V.382, C:V.382, A:L.307, A:F.310, A:F.311, A:F.311, A:M.314, A:A.318, A:V.376, A:I.379
- Hydrogen bonds: A:Q.304
- Salt bridges: A:K.303, A:K.303
LBN.10: 22 residues within 4Å:- Chain A: L.368, G.369, S.372, V.376, T.377, V.382
- Chain B: R.207, F.209, W.212, K.303, Q.304, L.307, F.310, F.311, M.314, A.318, S.372, A.375, V.376, S.378, I.379
- Chain C: M.314
16 PLIP interactions:11 interactions with chain B, 5 interactions with chain A- Hydrophobic interactions: B:L.307, B:F.310, B:F.311, B:F.311, B:M.314, B:A.318, B:V.376, B:I.379, A:L.368, A:V.376, A:T.377, A:V.382, A:V.382
- Hydrogen bonds: B:Q.304
- Salt bridges: B:K.303, B:K.303
LBN.16: 22 residues within 4Å:- Chain A: M.314
- Chain B: L.368, G.369, S.372, V.376, T.377, V.382
- Chain C: R.207, F.209, W.212, K.303, Q.304, L.307, F.310, F.311, M.314, A.318, S.372, A.375, V.376, S.378, I.379
16 PLIP interactions:5 interactions with chain B, 11 interactions with chain C- Hydrophobic interactions: B:L.368, B:V.376, B:T.377, B:V.382, B:V.382, C:L.307, C:F.310, C:F.311, C:F.311, C:M.314, C:A.318, C:V.376, C:I.379
- Hydrogen bonds: C:Q.304
- Salt bridges: C:K.303, C:K.303
- 6 x CLR: CHOLESTEROL(Non-covalent)
CLR.5: 8 residues within 4Å:- Chain A: L.272, L.275, A.279, L.282, G.445, I.448, I.454, K.457
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:L.272, A:L.275, A:I.448, A:I.454, A:I.454
CLR.6: 7 residues within 4Å:- Chain A: G.214, P.215, V.218, W.294, W.298, C.301, L.305
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:V.218, A:W.294, A:W.294, A:W.294, A:W.298, A:L.305
CLR.11: 8 residues within 4Å:- Chain B: L.272, L.275, A.279, L.282, G.445, I.448, I.454, K.457
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:L.272, B:L.275, B:I.448, B:I.454, B:I.454
CLR.12: 7 residues within 4Å:- Chain B: G.214, P.215, V.218, W.294, W.298, C.301, L.305
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:V.218, B:W.294, B:W.294, B:W.294, B:W.298, B:L.305
CLR.17: 8 residues within 4Å:- Chain C: L.272, L.275, A.279, L.282, G.445, I.448, I.454, K.457
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:L.272, C:L.275, C:I.448, C:I.454, C:I.454
CLR.18: 7 residues within 4Å:- Chain C: G.214, P.215, V.218, W.294, W.298, C.301, L.305
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:V.218, C:W.294, C:W.294, C:W.294, C:W.298, C:L.305
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chen, K. et al., Mechanism of stepwise electron transfer in six-transmembrane epithelial antigen of the prostate (STEAP) 1 and 2. Elife (2023)
- Release Date
- 2023-01-25
- Peptides
- Metalloreductase STEAP2: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
AC
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 3 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 3 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Covalent)
- 3 x LBN: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine(Non-covalent)
- 6 x CLR: CHOLESTEROL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chen, K. et al., Mechanism of stepwise electron transfer in six-transmembrane epithelial antigen of the prostate (STEAP) 1 and 2. Elife (2023)
- Release Date
- 2023-01-25
- Peptides
- Metalloreductase STEAP2: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
AC
C - Membrane
-
We predict this structure to be a membrane protein.